These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38739313)

  • 1. Regarding the double-negative T cells in patients with systemic sclerosis.
    Zhang Q; Huang Y
    Clin Rheumatol; 2024 Jul; 43(7):2361. PubMed ID: 38739313
    [No Abstract]   [Full Text] [Related]  

  • 2. Is systemic sclerosis an antigen-driven T cell disease?
    Sakkas LI; Platsoucas CD
    Arthritis Rheum; 2004 Jun; 50(6):1721-33. PubMed ID: 15188347
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell imbalance in progressive systemic sclerosis defined by monoclonal antibodies.
    Claudy AL; Le Petit JC; Barthelemy H; Garcier F
    Arch Dermatol Res; 1982; 274(1-2):189-92. PubMed ID: 6984640
    [No Abstract]   [Full Text] [Related]  

  • 4. Pathogenesis of progressive systemic sclerosis.
    Postlethwaite AE; Kang AH
    J Lab Clin Med; 1984 Apr; 103(4):506-10. PubMed ID: 6607964
    [No Abstract]   [Full Text] [Related]  

  • 5. Case history of a patient with multiple sclerosis and scleroderma.
    Jawad SH; Askari A; Ward AB
    Br J Rheumatol; 1997 Apr; 36(4):502-3. PubMed ID: 9159550
    [No Abstract]   [Full Text] [Related]  

  • 6. T-cell activation in the lungs of patients with systemic sclerosis and its relation with pulmonary fibrosis.
    Bresser P; Jansen HM; Weller FR; Lutter R; Out TA
    Chest; 2001 Jul; 120(1 Suppl):66S-68S. PubMed ID: 11451930
    [No Abstract]   [Full Text] [Related]  

  • 7. Circulating T and B lymphocytes in progressive systemic sclerosis.
    de Jesus DG; Clancy RL
    J Rheumatol; 1975 Sep; 2(3):336-9. PubMed ID: 1081143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cutaneous sclerosis and aplastic anemia with antithymocyte globulin.
    Balaban EP; Sheehan RG; Lipsky PE; Frenkel EP
    Ann Intern Med; 1987 Jan; 106(1):56-8. PubMed ID: 3491559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte markers in patients with progressive systemic sclerosis.
    Czirják L; Dankó K; Sonkoly I; Bodolay E; Szegedi G
    Acta Med Hung; 1985; 42(3-4):109-14. PubMed ID: 2937012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological alterations during photopheresis and D-penicillamine treatment of systemic sclerosis.
    Rietschel RL; Cooper ES
    Ann N Y Acad Sci; 1991 Dec; 636():400-2. PubMed ID: 1793227
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunology of systemic sclerosis.
    Artlett CM
    Front Biosci; 2005 May; 10():1707-19. PubMed ID: 15769660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies in childhood scleroderma.
    Stögmann W; Sandhofer M; Fritz J
    Eur J Pediatr; 1977 Feb; 124(3):223-30. PubMed ID: 300058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of immunoregulation in progressive systemic sclerosis. Evidence for excess helper-cell function and altered B-cell function.
    Krakauer RS; Sundeen J; Sauder DN; Scherbel A
    Arch Dermatol; 1981 Feb; 117(2):80-2. PubMed ID: 6451199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased spontaneous production of interleukin-1 together with inhibitory activity in systemic sclerosis.
    Westacott CI; Whicher JT; Hutton CW; Dieppe PA
    Clin Sci (Lond); 1988 Dec; 75(6):561-7. PubMed ID: 3264777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.
    Chizzolini C
    Springer Semin Immunopathol; 1999; 21(4):431-50. PubMed ID: 10945035
    [No Abstract]   [Full Text] [Related]  

  • 16. [Characteristics of cellular and humoral immunity in patients with systemic scleroderma].
    Iashchenko OB
    Vrach Delo; 1983 Feb; (2):61-4. PubMed ID: 6601883
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunology in scleroderma.
    Barnett AJ
    Med J Aust; 1978 Aug; 2(4):138-40. PubMed ID: 310015
    [No Abstract]   [Full Text] [Related]  

  • 18. Antilymphocyte antibodies in progressive systemic sclerosis.
    Labro MT; Perianin A; Kahn MF
    Clin Exp Rheumatol; 1983; 1(1):23-8. PubMed ID: 6398153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of lymphocyte reactivity by a low molecular weight cutaneous antigen in patients with progressive systemic sclerosis (scleroderma).
    Kondo H; Rabin BS; Rodnan GP
    J Rheumatol; 1979; 6(1):30-7. PubMed ID: 374734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of determining the lymphocyte subpopulations in the clinical evaluation of scleroderma in children].
    Levina SG; Geppa NA; Uvarova NN; Snesarevskaia IP
    Pediatriia; 1980 Apr; (4):50-2. PubMed ID: 6966790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.